Monday, December 15, 2008 4:22:27 PM
"frogdreaming,"
Nowhere does that quote contradict the fact that DNAPrint Genomics' intellectual property, in the Ancestry Informative Markers, is an advantage. My evidence is in the literature, and press reports, describing DNAPrint Genomics' AIMs (Ancestry Informative Markers,) which is readily accessible.
P.S., you flip-flopped on the insider trading restrictions issue. You were clearly claiming I was subject to insider trading restrictions (I am not, because I possess no insider information.) What I am subjected to is disclosure requirements, merely because I own more than a certain percentage of the outstanding shares of common stock. You flip-flopped in then trying to claim that's what you were talking about, all along. The argument is won: I am not, contrary to what you claimed, subject to insider trading restrictions. Merely disclosure requirements (disclosing my buys and sells, and information derived from that, specifically, percentage of outstanding shares that I own.) If you continue to flip-flop, and continue to refuse to retract anything you claimed that was since proven to be false, I will simply not take your statements seriously, at all, but will have to dismiss them as being nothing more than dishonest harassment.
Daniel Gannon
Portland, Oregon, USA
Mass Megawatts Announces $220,500 Debt Cancellation Agreement to Improve Financing and Sales of a New Product to be Announced on July 11 • MMMW • Jun 28, 2024 7:30 AM
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM